000			01250 a2200349 4500
005			20250513170032.0
264		0	_c19990315
008			199903s 0 0 eng d
022			_a0009-9147
040			_aNLM _beng _cNLM
100	1		_aJung, K
245	0	0	_aA gap between total prostate-specific antigen and the sum of free prostate-specific antigen plus alpha1-antichymotrypsin-prostate- specific antigen in patients with prostate carcinoma but not in those with benign prostate hyperplasia. _h[electronic resource]
260			_bClinical chemistry _cMar 1999
300			_a422-4 p. _bdigital
500			_aPublication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aProstate-Specific Antigen _xblood
650	0	4	_aProstatic Hyperplasia _xblood
650	0	4	_aProstatic Neoplasms _xblood
650	0	4	_aalpha 1-Antichymotrypsin _xblood
700	1		_aBrux, B
700	1		_aKnäbich, A
700	1		_aLein, M
700	1		_aSinha, P
700	1		_aSchnorr, D
700	1		_aLoening, S A
773	0		_tClinical chemistry _gvol. 45 _gno. 3 _gp. 422-4
999			_c10013559 _d10013559